Abstract
Rats with a history of daily (21 days) amphetamine (2.5 mg/kg) treatment showed enhanced activity when under placebo in their amphetamine-associated environment. We found that this conditioned effect was reduced by haloperidol (0.06; 0.125; 0.25 mg/kg), pimozide (0.25; 0.5 mg/kg) and sulpiride (8; 16; 32 mg/kg) but only at doses similar to or, in the case of pimozide, higher than those required to antagonize the unconditioned stimulant effects of amphetamine (2.5 mg/kg). Conversely, we observed that clonidine (7; 15; 30; 60 μg/kg) or lithium regimen (between days 15 and 21) leading to lithium plasma levels of 1.3±0.1 mEq/1, abolished amphetamine-conditioned hyperactivity but did not affect the unconditioned stimulation of amphetamine or locomotor activity in control rats. Moreover, we found that hyperactivity induced by the daily anticipation of food delivery shared identical pharmacological sensitivity with the behavioural excitation produced by a conditioning history with amphetamine. In light of the antimanic properties of lithium and clonidine and the ability of this latter drug to reduce noradrenergic transmission, our findings raise the posibility that incentive activity may model noradrenergic-dependent aspects of mania.
Similar content being viewed by others
References
Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314
Beninger RJ (1982) The behavioral function of dopamine. Behav Brain Sci 5:55–56
Beninger RJ, Hahn BL (1983) Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220:1304–1306
Edelson A, Gottesfeld Z, Samuel D, Yuwiler A (1976) Effect of lithium and other alkali metals on brain chemistry and behavior: Intracranial self-stimulation behavior. Psychopharmacologia 45:233–237
Gerbino L, Oleshansky M, Gershon S (1978) Clinical use and mode of action of lithium. In: Lipton MA, Di Mascio A, Killam KF (eds) Psychopharmacology: A generation of progress, Raven, New York, pp 1261–1275
Gerlach J, Behnke K, Heltberg J, Mund-Andersen E, Nielsen H (1985) Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations. Br J Psychiatry 174:283–288
Gerner RH, Fairbanks L, Anderson GM, Young JH, Scheinen M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ (1984) CSF neurochemistry in depressed, manic and schizophrenic patients compared with that of normal controls. Am J Psychiatry 141:1533–1540
Grant SJ, Redmond DE (1981) The neuroanatomy and pharmacology of the nucleus coeruleus. In: Lal H, Fielding S (eds) Psychopharmacology of clonidine. A.R. Liss, New York, pp 5–27
Hardy MC, Lecrubier Y, Widlocher H (1986) Efficacy of clonidine in 24 patients with acute mania. Am J Psychiatry 143:1450–1453
Jouvent R, Lecrubier Y, Puech AJ, Simon P, Widlocher D (1980) Antimanic effect of clonidine. Am J Psychiatry 1275:137–138
Lal H, Shearman GT (1981) Psychotropis actions of clonidine. In: Lal H, Fielding S (eds) Pharmacology of clonidine. Liss, New York, pp 99–145
Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481–497
Niemegeers CJE (1982) Antiemetic specificity of dopamine antagonists. Psychopharmacology 78:210–213
Oades RD (1985) The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci Biobehav Rev 9:261–282
Posluns D (1962) An analysis of chlorpromazine-induced supression of the avoidance response. Psychopharmacologia 3:361–373
Post RM, Jimerson DC, Bunney WE, Goodwin FK (1980) Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology 67:297–305
Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229–313
Simon P, Chermat R, Boissier JR (1975) Comparaison des effects sédatifs de deux β-sympathomimétiques antihypertenseurs: la clonidine et la tiaménidine. Thérapie 30:855–861
Solomon P, Crider A, Winkelman JW, Tori A, Damer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519–536
Swerdlow NR, Koob GF (1984) Restrained rats learn amphetamine-conditioned locomotion, but not place preference. Psychopharmacology 84:163–166
Taboada ME, Souto M, Hawkins H, Monti JM (1979) The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats. Psychopharmacology 62:83–88
Wise RA (1982) Neuroleptics and operant behaviour: the anhedonia hypothesis. Behav Brain Sci 5:39–87
Zubenko CS, Cohen BM, Lipinski JF, Jonas JM (1984) Clonidine in the treatment of mania and mixed bipolar disorder. Am J Psychiatry 141:1617–1618
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poncelet, M., Dangoumau, L., Soubrié, P. et al. Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology 92, 393–397 (1987). https://doi.org/10.1007/BF00210850
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00210850